CHEN K, ZHANG J, GU H. Dissolution from inside: a unique degradation behaviour of core-shell magnetic mesoporous silica nanoparticles and the effect of polyethyleneimine coating [J]. J Mater Chem, 2012, 22 (41): 22005-22012.
[2]
PETER A W, PHILIP J B, MARK A G. Synthesis of porous hollow silica nanostructures using hydroxyapatite nanoparticle templates [J]. Chem Commun, 2011, 47(5): 1568-1570.
[3]
PANG Y X, Bao X. Influence of temperature, ripening time and calcination on the morphology and crystallinity of hydroxyapatite nanoparticles [J]. J Eur Ceram Soc, 2003, 23(10): 1697-1704.
[4]
ZHANG H, DARVELL B W. Constitution and morphology of hydroxyapatite whiskers prepared using amine additives [J]. J Eur Ceram Soc, 2010, 30(10): 2041-2048.
[5]
LI C F, LIU S G, Li G C, et al. Hydrothermal synthesis of large-sized hydroxyapatite whiskers regulated by glutamic acid in solutions with low supersaturation of precipitation [J]. Adv Powder Technol, 2011; 22(4): 537-543.
[6]
PARALE V G, MAHADIK D B, MAHADIK S A,？ et al. Wettability study of surface modified silica aerogels with different silylating agents [J]. J Sol-Gel Sci Technol, 2012, 63(3): 573-579.
[7]
VAN OSS C J, GIESE R F, WU W. On the predominant electron donicity of polar solid surfaces [J]. J Adhesion Sci Tech, 1997, 63(1-3):71-78.
[8]
WU W, NANCOLLAS G H. Kinetics of heterogeneous nucleation of calcium phosphates on anatase and rutile surfaces [J]. J Colloid Interface Sci, 1998, 199(2): 206-211.
[9]
VAN OSS C J, CHAUDHURY M K, GOOD R J. Interfacial Lifshitzvan der Waals and polar interactions in macroscopic systems [J]. Chem Rev, 1988, 88(6): 927-941.
[10]
DEMBSKI S, MILDE M, DYRBA M, et al. Effect of pH on the synthesis and properties of luminescent SiO2/calcium phosphate:Eu3+ core-shell nanoparticles [J]. Langmuir, 2011, 27(23): 14025-14032.
[11]
ZHU Y, FANG Y, KASKEL S. Folate-conjugated Fe3O4@SiO2 hollow mesoporous spheres for targeted anticancer drug delivery [J]. J Phys Chem C, 2010, 114 (39): 16382-16388.
[12]
CURREY J. Biomaterials: sacrificial bonds heal bone [J]. Nature, 2001, 414(6865): 699.
[13]
MARK K, YASSER H, TODD F, et al. Calcium phosphate nanocomposite particles for in vitro imaging and encapsulated chemotherapeutic drug delivery to cancer cells [J]. Nano Lett, 2008, 8 (12): 4116-4121.
[14]
.CHEN F, ZHU Y J, ZHANG K H, et al. Europium-doped amorphous calcium phosphate porous nanospheres: preparation and application as luminescent drug carriers [J]. Nanoscale Res Lett, 2011, 6(1): 67-75.
[15]
LI C F, LI G C, LIU S G, et al. Spherical hydroxyapatite with colloidal stability prepared in aqueous solutions containing polymer/surfactant pair [J]. Colloids Surf A, 2010, 366 (1/3): 27-33.
[16]
LUO Y, LING Y, GUO W, et al. Docetaxel loaded oleic acidcoated hydroxyapatite nanoparticles enhance the docetaxel-induced apoptosis through activation of caspase-2 in androgen independent prostate cancer cells [J]. J Control Release, 2010, 147 (2): 278-288.
[17]
LAI C Y, BRAIN G T, DUSAN M J, et al. A mesoporous silica nanosphere-based carrier system with chemically removable CdS nanoparticle caps for stimuli-responsive controlled release of neurotransmitters and drug molecules [J]. J Am Chem Soc, 2003, 125(15): 4451-4459.
[18]
ZOU Z, HE D, HE X, et al. Natural gelatin capped mesoporous silica nanoparticles for intracellular acidtriggered drug delivery [J]. Langmuir, 2013, 29 (41): 12804-12810.
[19]
LIU J W, JIANG X M, ASHLEY C, et al. Electrostatically mediated liposome fusion and lipid exchangewith a nanoparticle-supported bilayer for control of surface charge, drug containment, and delivery [J]. J Am Chem Soc, 2009, 131(22): 7567-7569.
[20]
YUAN L, TANG Q, YANG D, et al. Preparation of pH-responsive mesoporous silica nanoparticles and their application in controlled drug delivery [J]. J Phys Chem C, 2011, 115(20): 9926-9932.
[21]
TSYALKOVSKY V, BURTOVYY R, KLEP V, et al. Fluorescent nanoparticles stabilized by poly(ethylene glycol) containing shell for pH-triggered tunable aggregation in aqueous environment [J]. Langmuir, 2010, 26(13): 10684-10692.
[22]
ZHOU S, DU X, CUI F, et al. Multi-responsive and logic controlled release of DNA-gated mesoporous silica vehicles functionalized with intercalators for multiple delivery [J]. Small, DOI: 10-1002/smll.201302312.
[23]
ZHANG S, CHU Z, YIN C, et al. Controllable drug release and simultaneously carrier decomposition of SiO2-drug composite nanoparticles [J]. J Am Chem Soc, 2013, 135(15): 5709-5716.
[24]
LIN Y S, Katie R, HURLEY K R, et al. Critical Considerations in the biomedical use of mesoporous silica nanoparticles [J]. J Phys Chem Lett, 2012, 3(3): 364-374.
[25]
MA K, SAI H, WIESNER U. Ultrasmall sub-10nm near-infrared fluorescent mesoporous ailica nanoparticles [J]. J Am Chem Soc, 2012, 134(32): 13180-13183.
[26]
LI X, ZHANG L, DONG X, et al. Preparation of mesoporous calcium doped silica spheres with narrow size dispersion and their drug loading and degradation behavior [J]. Micropor Mesopor Mater, 2007, 102(1-3): 151-158.
[27]
MITCHELL K K P, LIBERMAN A, KUMMEL A C, et al. Iron(III)-doped, silica nanoshells: a biodegradable form of silica [J]. J Am Chem Soc, 2012, 134 (34): 13997-14003.
